Life ScienceCompany
Who owns Agilis Biotherapeutics?
Agilis Biotherapeutics is owned by PTC Therapeutics. It was acquired in 2018.
Agilis Biotherapeutics is owned by PTC Therapeutics. It was acquired in 2018.
245 First Street Kendall Square, Suite 1800,
Cambridge, Massachusetts
02142
United States,
(214) 706-4340
www.agilisbio.com
| Status | Dates | Investor(s) | |
|---|---|---|---|
| Investment | Exit | ||
| Current | 2018-07-19 | PTC Therapeutics | |
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.